What causes acute coronary syndromes? Applying Koch's postulates

Atherosclerosis

Volumn 179, Issue 1, 2005, Pages 1-15

  Monaco, Claudia ^b   Mathur, Anthony ^c   Martin, John F ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Acute coronary syndromes; Cholesterol; Inflammation; Platelets; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 9; CHOLESTEROL; FIBRIN; FIBRINOGEN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; FIBRIN FORMATION; FIBRINOLYSIS; HEART INFARCTION; HUMAN; INFLAMMATION; INTIMA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE; THROMBOGENICITY; UNSTABLE ANGINA PECTORIS; VASCULAR ENDOTHELIUM;

EID: 13844256213     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.10.022     Document Type: Review

References (255)

1. Koch R. Classics in infectious diseases. The etiology of tuberculosis: Robert Koch, Berlin, Germany, 1882.
2. L.A. Solberg, J.P. Strong, and I. Holme Stenoses in the coronary arteries Relation to atherosclerotic lesions, coronary heart disease, and risk factors Oslo Study Lab Invest 53 1985 648 655
3. E.M. Tuzcu, S.R. Kapadia, and E. Tutar High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound Circulation 103 2001 2705 2710
4. D. Hackett, G. Davies, and A. Maseri Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe Eur Heart J 9 1988 1317 1323
5. J.A. Ambrose, M.A. Tannenbaum, and D. Alexopoulos Angiographic progression of coronary artery disease and the development of myocardial infarction J Am Coll Cardiol 12 1988 56 62
6. P. Costantidines Plaque fissuring in human coronary thrombosis LJ Atheroscler Res 6 1966 1 7
7. A.B. Chandler Mechanisms and frequency of thrombosis in the coronary circulation Thromb Res 4 Suppl 1 1974 3 23
8. E. Falk Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi Br Heart J 50 1983 127 134
9. M.J. Davies, and A. Thomas Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death N Engl J Med 310 1984 1137 1140
10. M.J. Davies, and A.C. Thomas Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina Br Heart J 53 1985 363 373
11. E. Falk Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion Circulation 71 1985 699 708
12. M.J. Davies, J.M. Bland, J.R. Hangartner, A. Angelini, and A.C. Thomas Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death Eur Heart J 10 1989 203 208
13. M.J. Davies A macro and micro view of coronary vascular insult in ischemic heart disease Circulation 82 1990 II38 II46
14. A.H. Kragel, S.D. Gertz, and W.C. Roberts Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction J Am Coll Cardiol 18 1991 801 808
15. E. Falk Why do plaques rupture? Circulation 86 1992 III-30 III-42
16. M.J. Davies, P.D. Richardson, N. Woolf, D.R. Katz, and J. Mann Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content Br Heart J 69 1993 377 381
17. M.J. Davies Stability and instability: two faces of coronary atherosclerosis The Paul Dudley White Lecture Circulation 94 1996 2013 2020
18. C. Depre, W. Wijns, A.M. Robert, J.P. Renkin, and X. Havaux Pathology of unstable plaque: correlation with the clinical severity of acute coronary syndromes J Am Coll Cardiol 30 1997 694 702
19. E. Falk, P.K. Shah, and V. Fuster Coronary plaque disruption Circulation 92 1995 657 671
20. V. Fuster, B. Stein, and J.A. Ambrose Atherosclerotic plaque rupture and thrombosis Evolving concepts Circulation 82 1990 II47 II59
21. A.C. Van der Wal, A.E. Becker, C.M. van der Loos, and P.K. Das Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology Circulation 89 1994 36 44
22. A. Farb, A.P. Burke, and A.L. Tang Coronary plaque erosion without rupture into a lipid core A frequent cause of coronary thrombosis in sudden coronary death Circulation 93 1996 1354 1363
23. A.P. Burke, A. Farb, and G.T. Malcom Coronary risk factors and plaque morphology in men with coronary disease who died suddenly N Engl J Med 336 1997 1276 1282
24. M. Naghavi, P. Libby, and E. Falk From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies Part II Circulation 108 2003 1772 1778
25. M. Naghavi, P. Libby, and E. Falk From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies Part I Circulation 108 2003 1664 1672
26. F.D. Kolodgie, H.K. Gold, and A.P. Burke Intraplaque hemorrhage and progression of coronary atheroma N Engl J Med 349 2003 2316 2325
27. J.A. Ambrose, S.L. Winters, and R.R. Arora Angiographic evolution of coronary artery morphology in unstable angina J Am Coll Cardiol 7 1986 472 478
28. M.R. Freeman, A.E. Williams, R.J. Chisholm, and P.W. Armstrong Intracoronary thrombus and complex morphology in unstable angina Relation to timing of angiography and in-hospital cardiac events Circulation 80 1989 17 23
29. J.A. Ambrose, C. Hjemdahl-Monsen, and S. Borrico Quantitative and qualitative effects of intracoronary streptokinase in unstable angina and non-Q wave infarction J Am Coll Cardiol 9 1987 1156 1165
30. G. Dangas, R. Mehran, and S. Wallenstein Correlation of angiographic morphology and clinical presentation in unstable angina J Am Coll Cardiol 29 1997 519 525
31. J.A. Goldstein, D. Demetriou, and C.L. Grines Multiple complex coronary plaques in patients with acute myocardial infarction N Engl J Med 343 2000 915 922
32. C.T. Sherman, F. Litvack, and W. Grundfest Coronary angioscopy in patients with unstable angina pectoris N Engl J Med 315 1986 913 919
33. K. Mizuno, A. Miyamoto, and K. Satomura Angioscopic coronary macromorphology in patients with acute coronary disorders Lancet 337 1991 809 812
34. K. Mizuno, K. Satomura, and A. Miyamoto Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes N Engl J Med 326 1992 287 291
35. T. Thieme, K.D. Wernecke, and R. Meyer Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes J Am Coll Cardiol 28 1996 1 6
36. S. Feld, M. Ganim, and E.S. Carell Comparison of angioscopy, intravascular ultrasound imaging and quantitative coronary angiography in predicting clinical outcome after coronary intervention in high risk patients J Am Coll Cardiol 28 1996 97 105
37. S. Sakai, K. Mizuno, and S. Yokoyama Morphologic changes in infarct-related plaque after coronary stent placement: a serial angioscopy study J Am Coll Cardiol 42 2003 1558 1565
38. G. Rioufol, G. Finet, and I. Ginon Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study Circulation 106 2002 804 808
39. R.T. Lee, and P. Libby The unstable atheroma Arterioscler Thromb Vasc Biol 17 1997 1859 1867
40. R. Virmani, A.P. Burke, F.D. Kolodgie, and A. Farb Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque J Interv Cardiol 16 2003 267 272
41. R.M. Botnar, M. Stuber, and K.V. Kissinger Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging Circulation 102 2000 2582 2587
42. R. Corti, Z.A. Fayad, and V. Fuster Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging Circulation 104 2001 249 252
43. Z.A. Fayad, J.T. Fallon, and M. Shinnar Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice Circulation 98 1998 1541 1547
44. Z.A. Fayad, V. Fuster, and J.T. Fallon Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging Circulation 102 2000 506 510
45. T.S. Hatsukami, R. Ross, N.L. Polissar, and C. Yuan Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging Circulation 102 2000 959 964
46. M. Mutin, I. Canavy, and A. Blann Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells Blood 93 1999 2951 2958
47. J.F. Toussaint, G.M. LaMuraglia, J.F. Southern, V. Fuster, and H.L. Kantor Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo Circulation 94 1996 932 938
48. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes Part II N Engl J Med 326 1992 310 318
49. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes Part I N Engl J Med 326 1992 242 250
50. P.D. Richardson, M.J. Davies, and G.V. Born Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques Lancet 2 1989 941 944
51. G. Caligiuri, B. Levy, J. Pernow, P. Thoren, and G.K. Hansson Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice Proc Natl Acad Sci USA 96 1999 6920 6924
52. P. Libby Molecular bases of the acute coronary syndromes Circulation 91 1995 2844 2850
53. P.K. Shah Plaque disruption and coronary thrombosis: new insight into pathogenesis and prevention Clin Cardiol 20 1997 II-38 II-44
54. L.G. Spagnoli, E. Bonanno, and A. Mauriello Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction J Am Coll Cardiol 40 2002 1579 1588
55. M.J. Davies, J.L. Gordon, and A.J. Gearing The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis J Pathol 171 1993 223 229
56. A.C. Van der Wal, A.E. Becker, and P.K. Das The expression of adhesion molecules on endothelial cells in atherosclerosis has a topographic relationship with the underlying inflammatory process Histopathology 24 1994 200 201
57. H. Drexler, A.M. Zeiher, and H. Wollschlager Flow-dependent coronary artery dilatation in humans Circulation 80 1989 466 474
58. J.M. Hodgson, and J.J. Marshall Direct vasoconstriction and endothelium-dependent vasodilation Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries Circulation 79 1989 1043 1051
59. D.A. Cox, J.A. Vita, and C.B. Treasure Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans Circulation 80 1989 458 465
60. J.A. Vita, C.B. Treasure, and P. Ganz Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis J Am Coll Cardiol 14 1989 1193 1199
61. A.M. Zeiher, H. Drexler, H. Wollschlaeger, B. Saurbier, and H. Just Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium J Am Coll Cardiol 14 1989 1181 1190
62. N.G. Uren, T. Crake, and D.C. Lefroy Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction N Engl J Med 331 1994 222 227
63. P.M. Ridker, C.H. Hennekens, B. Roitman-Johnson, M.J. Stampfer, and J. Allen Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men Lancet 351 1998 88 92
64. A. Chinellato, E. Ragazzi, and L. Petrelli Effect of cholesterol- supplemented diet in heritable hyperlipidemic Yoshida rats: functional and morphological characterization of thoracic aorta Atherosclerosis 106 1994 51 63
65. A.A. Kroon, A.F. Stalenhoef, and H. Buikema The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbits Atherosclerosis 103 1993 221 230
66. Y. Kawachi, H. Tomoike, and Y. Maruoka Selective hypercontraction caused by ergonovine in the canine coronary artery under conditions of induced atherosclerosis Circulation 69 1984 441 450
67. H. Shimokawa, and P.M. Vanhoutte Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis Circ Res 64 1989 900 914
68. H. Shimokawa, and P.M. Vanhoutte Hypercholesterolemia causes generalized impairment of endothelium-dependent relaxation to aggregating platelets in porcine arteries J Am Coll Cardiol 13 1989 1402 1408
69. H. Shimokawa, and P.M. Vanhoutte Angiographic demonstration of hyperconstriction induced by serotonin and aggregating platelets in porcine coronary arteries with regenerated endothelium J Am Coll Cardiol 17 1991 1197 1202
70. C.B. Treasure, J.L. Klein, and W.S. Weintraub Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N Engl J Med 332 1995 481 487
71. W.H. Leung, C.P. Lau, and C.K. Wong Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients Lancet 341 1993 1496 1500
72. E.S. Stroes, H.A. Koomans, T.W. de Bruin, and T.J. Rabelink Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication Lancet 346 1995 467 471
73. G. O'Driscoll, D. Green, and R.R. Taylor Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month Circulation 95 1997 1126 1131
74. O. Tamai, H. Matsuoka, and H. Itabe Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans Circulation 95 1997 76 82
75. J. Dupuis, J.C. Tardif, P. Cernacek, and P. Theroux Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial Circulation 99 1999 3227 3233
76. V. Fuster, Z.A. Fayad, and J.J. Badimon Acute coronary syndromes: biology Lancet 353 Suppl 2 1999 SII5 SII9
77. T.S. Edgington, N. Mackman, K. Brand, and W. Ruf The structural biology of expression and function of tissue factor Thromb Haemost 66 1991 67 79
78. S.M. Zeldis, Y. Nemerson, and F.A. Pitlick Tissue factor (thromboplastin): localization to plasma membranes by peroxidase-conjugated antibodies Science 175 1972 766 768
79. J.N. Wilcox, K.M. Smith, S.M. Schwartz, and D. Gordon Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque Proc Natl Acad Sci USA 86 1989 2839 2843
80. P.R. Moreno, V.H. Bernardi, and J. Lopez-Cuellar Macrophages, smooth muscle cells, and tissue factor in unstable angina Implications for cell-mediated thrombogenicity in acute coronary syndromes Circulation 94 1996 3090 3097
81. V. Toschi, R. Gallo, and M. Lettino Tissue factor modulates the thrombogenicity of human atherosclerotic plaques Circulation 95 1997 594 599
82. S.I. Rapaport, and L.V. Rao Initiation and regulation of tissue factor-dependent blood coagulation Arterioscler Thromb 12 1992 1111 1121
83. D.M. Monroe, M. Hoffman, and H.R. Roberts Transmission of a procoagulant signal from tissue factor-bearing cell to platelets Blood Coagul Fibrinolysis 7 1996 459 464
84. D. Ardissino, P.A. Merlini, and R. Ariens Tissue-factor antigen and activity in human coronary atherosclerotic plaques Lancet 349 1997 769 771
85. B. Jude, B. Agraou, and E.P. McFadden Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina Circulation 90 1994 1662 1668
86. V. Balasubramanian, E. Grabowski, A. Bini, and Y. Nemerson Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions Blood 100 2002 2787 2792
87. P.L. Giesen, and Y. Nemerson Tissue factor on the loose Semin Thromb Hemost 26 2000 379 384
88. P.L. Giesen, U. Rauch, and B. Bohrmann Blood-borne tissue factor: another view of thrombosis Proc Natl Acad Sci USA 96 1999 2311 2315
89. M. Aikawa, S.J. Voglic, and S. Sugiyama Dietary lipid lowering reduces tissue factor expression in rabbit atheroma Circulation 100 1999 1215 1222
90. D. Corseaux, T. Le Tourneau, and I. Six Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit: inhibition with dietary l-arginine Circulation 98 1998 1776 1782
91. D. Hasenstab, H. Lea, C.E. Hart, S. Lok, and A.W. Clowes Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis Circulation 101 2000 2651 2657
92. J.J. Badimon, M. Lettino, and V. Toschi Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions Circulation 99 1999 1780 1787
93. B. Arnljots, T. Soderstrom, M. Ezban, and U. Hedner Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis Blood Coagul Fibrinolysis 11 Suppl 1 2000 S145 S148
94. B. Jilma, C. Marsik, and F. Mayr Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans Clin Pharmacol Ther 72 2002 403 410
95. E.I. Lev, J.D. Marmur, and M. Zdravkovic Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human study Arterioscler Thromb Vasc Biol 22 2002 1036 1041
96. K.A. Fox, S.R. Bergmann, and C.J. Mathias Scintigraphic detection of coronary artery thrombi in patients with acute myocardial infarction J Am Coll Cardiol 4 1984 975 986
97. J.T. Willerson, P. Golino, J. Eidt, W.B. Campbell, and L.M. Buja Specific platelet mediators and unstable coronary artery lesions Experimental evidence and potential clinical implications Circulation 80 1989 198 205
98. A.M. Zeiher, H. Goebel, V. Schachinger, and C. Ihling Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina Circulation 91 1995 941 947
99. A. Maseri, A. L'Abbate, and G. Baroldi Coronary vasospasm as a possible cause of myocardial infarction A conclusion derived from the study of "preinfarction" angina N Engl J Med 299 1978 1271 1277
100. P. Bogaty, D. Hackett, G. Davies, and A. Maseri Vasoreactivity of the culprit lesion in unstable angina Circulation 90 1994 5 11
101. J.F. Martin, P.M. Bath, and M.L. Burr Influence of platelet size on outcome after myocardial infarction Lancet 338 1991 1409 1411
102. A. Mathur, M.S. Robinson, J. Cotton, J.F. Martin, and J.D. Erusalimsky Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction Thromb Haemost 85 2001 989 994
103. H. Giles, R.E. Smith, and J.F. Martin Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction Eur J Clin Invest 24 1994 69 72
104. P.M. Bath, S.D. Kristensen, J.F. Martin, and P.C. Milner Bleeding time and diagnosis of acute myocardial infarction Haemostasis 21 1991 181 182 [letter]
105. S.D. Kristensen, P.M. Bath, and J.F. Martin Differences in bleeding time, aspirin sensitivity and adrenaline between acute myocardial infarction and unstable angina Cardiovasc Res 24 1990 19 23
106. J.D. Folts, E.B. Crowell Jr., and G.G. Rowe Platelet aggregation in partially obstructed vessels and its elimination with aspirin Circulation 54 1976 365 370
107. S.R. Hanson, H.F. Kotze, B. Savage, and L.A. Harker Platelet interactions with Dacron vascular grafts A model of acute thrombosis in baboons Arteriosclerosis 5 1985 595 603
108. S.R. Hanson, F.I. Pareti, and Z.M. Ruggeri Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon J Clin Invest 81 1988 149 158
109. L.A. Harker, U.M. Marzec, and A.B. Kelly Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates Circulation 98 1998 2461 2469
110. L. Badimon, J. Martinez-Gonzalez, T. Royo, R. Lassila, and J.J. Badimon A sudden increase in plasma epinephrine levels transiently enhances platelet deposition on severely damaged arterial wall - studies in a porcine model Thromb Haemost 82 1999 1736 1742
111. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Lancet 2 1988 349 360
112. Collaborative overview of randomised trials of antiplatelet therapy I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration Br Med J 308 1994 81 106
113. H.D. Lewis Jr., J.W. Davis, and D.G. Archibald Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina Results of a Veterans Administration Cooperative Study N Engl J Med 309 1983 396 403
114. J.A. Cairns, M. Gent, and J. Singer Aspirin, sulfinpyrazone, or both in unstable angina Results of a Canadian multicenter trial N Engl J Med 313 1985 1369 1375
115. Steering Committee of the Physicians' Health Study Research Group Final report on the aspirin component of the ongoing Physicians' Health Study N Engl J Med 321 1989 129 135
116. R. Peto, R. Gray, and R. Collins Randomised trial of prophylactic daily aspirin in British male doctors Br Med J (Clin Res Ed) 296 1988 313 316
117. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk The Medical Research Council's General Practice Research Framework Lancet 351 1998 233 241
118. G. de Gaetano Low-dose aspirin and Vitamin E in people at cardiovascular risk: a randomised trial in general practice Collaborative Group of the Primary Prevention Project Lancet 357 2001 89 95
119. S.P. Schulman, P.J. Goldschmidt-Clermont, and E.J. Topol Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina A randomized multicenter trial Circulation 94 1996 2083 2089
120. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes Platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy. The PURSUIT Trial Investigators N Engl J Med 339 1998 436 443
121. International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina Platelet IIb/IIIa antagonism for the reduction of acute coronary syndrome events in a Global Organization Network. The PARAGON Investigators Circulation 97 1998 2386 2395
122. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators N Engl J Med 338 1998 1498 1505
123. L.R. Erhardt, G. Unge, and G. Boman Formation of coronary arterial thrombi in relation to onset of necrosis in acute myocardial infarction in man A clinical and autoradiographic study Am Heart J 91 1976 592 598
124. R.L. Wilensky, J.A. Zeller, M. Wish, and M. Tulchinsky Urinary fibrinopeptide A levels in ischemic heart disease J Am Coll Cardiol 14 1989 597 603
125. L. Wilhelmsen, K. Svardsudd, and K. Korsan-Bengtsen Fibrinogen as a risk factor for stroke and myocardial infarction N Engl J Med 311 1984 501 505
126. T.W. Meade, S. Mellows, and M. Brozovic Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study Lancet 2 1986 533 537
127. T.W. Meade, V. Ruddock, Y. Stirling, R. Chakrabarti, and G.J. Miller Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study Lancet 342 1993 1076 1079
128. W.B. Kannel, R.B. D'Agostino, and A.J. Belanger Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study Am Heart J 113 1987 1006 1010
129. J.W. Yarnell, I.A. Baker, and P.M. Sweetnam Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease The Caerphilly and Speedwell collaborative heart disease studies Circulation 83 1991 836 844
130. K.K. Wu, A.R. Folsom, and G. Heiss Association of coagulation factors and inhibitors with carotid artery atherosclerosis Early results of the Atherosclerosis Risk in Communities (ARIC) Study Ann Epidemiol 2 1992 471 480
131. J. Heinrich, L. Balleisen, H. Schulte, G. Assmann, and J. van de Loo Fibrinogen and factor VII in the prediction of coronary risk Results from the PROCAM study in healthy men Arterioscler Thromb 14 1994 54 59
132. R.P. Tracy, E.G. Bovill, and D. Yanez Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly Results from The Cardiovascular Health Study Arterioscler Thromb Vasc Biol 15 1995 1269 1279
133. J. Ma, C.H. Hennekens, P.M. Ridker, and M.J. Stampfer A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study J Am Coll Cardiol 33 1999 1347 1352
134. M. Saigo, P.Y. Hsue, and D.D. Waters Role of thrombotic and fibrinolytic factors in acute coronary syndromes Prog Cardiovasc Dis 46 2004 524 538
135. A. Hamsten, B. Wiman, U. de Faire, and M. Blomback Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction N Engl J Med 313 1985 1557 1563
136. F. Van de Werf, S.R. Bergmann, and K.A. Fox Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology Circulation 69 1984 605 610
137. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) Lancet 1 1986 397 402
138. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction The GUSTO Investigators N Engl J Med 329 1993 673 682
139. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction The GUSTO Angiographic Investigators N Engl J Med 329 1993 1615 1622
140. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial Assessment of the Safety and Efficacy of a New Thrombolytic Investigators Lancet 354 1999 716 722
141. C.P. Cannon, C.M. Gibson, and C.H. McCabe TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators Circulation 98 1998 2805 2814
142. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Lancet 343 1994 311 322
143. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction Results of the Thrombolysis in Myocardial Ischemia (TIMI) IIIB Trial Circulation 89 1994 1545 1556
144. F.W. Bar, F.W. Verheugt, and J. Col Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome Results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase Circulation 86 1992 131 137
145. M.R. Freeman, A. Langer, R.F. Wilson, C.D. Morgan, and P.W. Armstrong Thrombolysis in unstable angina Randomized double-blind trial of t-PA and placebo Circulation 85 1992 150 157
146. M. Cohen, C. Demers, and E.P. Gurfinkel A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group N Engl J Med 337 1997 447 452
147. P. Theroux, H. Ouimet, and J. McCans Aspirin, heparin, or both to treat acute unstable angina N Engl J Med 319 1988 1105 1111
148. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease The RISC Group Lancet 336 1990 827 830
149. Low-molecular-weight heparin during instability in coronary artery disease Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group Lancet 347 1996 561 568
150. W. Klein, A. Buchwald, and W.S. Hillis Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease Am J Cardiol 80 1997 30 34
151. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators N Engl J Med 335 1996 775 782
152. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators Lancet 353 1999 429 438
153. S.S. Anand, S. Yusuf, J. Pogue, J.I. Weitz, and M. Flather Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results Circulation 98 1998 1064 1070
154. M.S. Brown, and J.L. Goldstein Koch's postulates for cholesterol Cell 71 1992 187 188
155. G. Assmann, and H. Schulte Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster Study Am J Cardiol 70 1992 733 737
156. W.M. Verschuren, D.R. Jacobs, and B.P. Bloemberg Serum total cholesterol and long-term coronary heart disease mortality in different cultures Twenty-five-year follow-up of the seven countries study J Am Med Assoc 274 1995 131 136
157. P.W. Wilson, W.B. Kannel, H. Silbershatz, and R.B. D'Agostino Clustering of metabolic factors and coronary heart disease Arch Intern Med 159 1999 1104 1109
158. J.D. Neaton, H. Blackburn, and D. Jacobs Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial Multiple Risk Factor Intervention Trial Research Group Arch Intern Med 152 1992 1490 1500
159. J.C. LaRosa, D. Hunninghake, and D. Bush The cholesterol facts A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association Circulation 81 1990 1721 1733
160. M.R. Law, N.J. Wald, and S.G. Thompson By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br Med J 308 1994 367 372
161. M.R. Law, N.J. Wald, T. Wu, A. Hackshaw, and A. Bailey Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study Br Med J 308 1994 363 366
162. J.L. Breslow Mouse models of atherosclerosis Science 272 1996 685 688
163. D. Steinberg Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime Nat Med 8 2002 1211 1217
164. D. Steinberg Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
165. J. Shepherd, S.M. Cobbe, and I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia West of Scotland Coronary Prevention Study Group N Engl J Med 333 1995 1301 1307
166. G.C. Flaker, J.W. Warnica, and F.M. Sacks Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations Cholesterol and Recurrent Events (CARE) Investigators J Am Coll Cardiol 34 1999 106 112
167. J.R. Downs, M. Clearfield, and S. Weis Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS, Air Force/Texas Coronary Atherosclerosis
168. D.J. Maron, S. Fazio, and M.F. Linton Current perspectives on statins Circulation 101 2000 207 213
169. G.G. Schwartz, A.G. Olsson, and M.D. Ezekowitz Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial J Am Med Assoc 285 2001 1711 1718
170. C.H. Ahsan, A. Shah, and M. Ezekowitz Acute statin treatment in reducing risk after acute coronary syndrome: the MIRACL (Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering) Trial Curr Opin Cardiol 16 2001 390 393
171. J.A. De Lemos, M.A. Blazing, and S.D. Wiviott Early intensive vs. a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial J Am Med Assoc 2004
172. L.K. Newby, A. Kristinsson, and M.V. Bhapkar Early statin initiation and outcomes in patients with acute coronary syndromes J Am Med Assoc 287 2002 3087 3095
173. J.W. Jukema, A.V. Bruschke, and A.J. van Boven Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels The Regression Growth Evaluation Statin Study (REGRESS) Circulation 91 1995 2528 2540
174. S.E. Nissen, E.M. Tuzcu, and P. Schoenhagen Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial J Am Med Assoc 291 2004 1071 1080
175. J.P. Halcox, and J.E. Deanfield Beyond the laboratory: clinical implications for statin pleiotropy Circulation 109 2004 II42 II48
176. P. Libby, and M. Aikawa Stabilization of atherosclerotic plaques: new mechanisms and clinical targets Nat Med 8 2002 1257 1262
177. P.M. Ridker, N. Rifai, and M.A. Pfeffer Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels Cholesterol and Recurrent Events (CARE) Investigators Circulation 98 1998 839 844
178. P.M. Ridker, N. Rifai, M.A. Pfeffer, F. Sacks, and E. Braunwald Long-term effects of pravastatin on plasma concentration of C-reactive protein The Cholesterol and Recurrent Events (CARE) Investigators Circulation 100 1999 230 235
179. P.M. Ridker, N. Rifai, and M. Clearfield Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events N Engl J Med 344 2001 1959 1965
180. R. Virchow Der atheromatose Prozess der Arterien Wien Med Wochenschr 6 1856 825 828
181. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
182. C. Monaco, E. Andreakos, S. Kiriakidis, M. Feldmann, and E. Paleolog T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases Curr Drug Targets Inflamm Allergy 3 2004 35 42
183. A.H. Kragel, S.G. Reddy, J.T. Wittes, and W.C. Roberts Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest Am J Cardiol 66 1990 562 567
184. A.C. Van der Wal, P.K. Das, D. Bentz van de Berg, C.M. van der Loos, and A.E. Becker Atherosclerotic lesions in humans In situ immunophenotypic analysis suggesting an immune mediated response Lab Invest 61 1989 166 170
185. O.J. de Boer, F. Hirsch, and A.C. van der Wal Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation Atherosclerosis 133 1997 227 234
186. G.K. Hansson, L. Jonasson, and B. Lojsthed Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques Atherosclerosis 72 1988 135 141
187. G.K. Hansson, J. Holm, and L. Jonasson Detection of activated T lymphocytes in the human atherosclerotic plaque Am J Pathol 135 1989 169 175
188. G.K. Hansson Immunological markers of atherosclerosis Lancet 341 1993 278
189. G.K. Hansson Immune and inflammatory mechanisms in the development of atherosclerosis Br Heart J 69 1993 S38 S41
190. G.K. Hansson Immunological control mechanisms in plaque formation Basic Res Cardiol 1 1994 41 46
191. A.C. Van der Wal, P.K. Das, A.J. Tigges, and A.E. Becker Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions Am J Pathol 141 1992 1427 1433
192. P. Barath, M.C. Fishbein, and J. Cao Detection and localization of tumor necrosis factor in human atheroma Am J Cardiol 65 1990 297 302
193. J.N. Wilcox, N.A. Nelken, S.R. Coughlin, D. Gordon, and T.J. Schall Local expression of inflammatory cytokines in human atherosclerotic plaques J Atheroscler Thromb 1 Suppl 1 1994 S10 S13
194. P. Libby, G. Sukhova, R.T. Lee, and Z.S. Galis Cytokines regulate vascular functions related to stability of the atherosclerotic plaque J Cardiovasc Pharmacol 25 1995 S9 S12
195. A.C. Van der Wal, A.E. Becker, and K.T. Koch Clinically stable angina pectoris is not necessarily associated with histologically stable atherosclerotic plaques Heart 76 1996 312 316
196. A.C. Van der Wal, J.J. Piek, and O.J. de Boer Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes Heart 80 1998 14 18
197. M. Meuwissen, A.C. van der Wal, and K.T. Koch Association between complex coronary artery stenosis and unstable angina and the extent of plaque inflammation Am J Med 114 2003 521 527
198. M. Meuwissen, J.J. Piek, and A.C. van der Wal Recurrent unstable angina after directional coronary atherectomy is related to the extent of initial coronary plaque inflammation J Am Coll Cardiol 37 2001 1271 1276
199. M. Hosono, O.J. de Boer, and A.C. van der Wal Increased expression of T cell activation markers (CD25, CD26, CD40L and CD69) in atherectomy specimens of patients with unstable angina and acute myocardial infarction Atherosclerosis 168 2003 73 80
200. D.L. Brown, M.S. Hibbs, M. Kearney, C. Loushin, and J.M. Isner Identification of 92-kDa gelatinase in human coronary atherosclerotic lesions Association of active enzyme synthesis with unstable angina Circulation 91 1995 2125 2131
201. A. Buffon, L.M. Biasucci, and G. Liuzzo Widespread coronary inflammation in unstable angina N Engl J Med 347 2002 5 12
202. A. Maseri, and Inflammation atherosclerosis and ischemic events - exploring the hidden side of the moon N Engl J Med 336 1997 1014 1016
203. G.G. Neri Serneri, R. Abbate, and A.M. Gori Transient intermittent lymphocyte activation is responsible for the instability of angina Circulation 86 1992 790 797
204. G.G. Neri Serneri, D. Prisco, and F. Martini Acute T-cell activation is detectable in unstable angina Circulation 95 1997 1806 1812
205. G. Caligiuri, G. Liuzzo, L.M. Biasucci, and A. Maseri Immune system activation follows inflammation in unstable angina: pathogenetic implications J Am Coll Cardiol 32 1998 1295 1304
206. J.L. Dinerman, J.L. Mehta, and T.G. Saldeen Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction J Am Coll Cardiol 15 1990 1559 1563
207. J. Mehta, J. Dinerman, and P. Mehta Neutrophil function in ischemic heart disease Circulation 79 1989 549 556
208. A. Mazzone, S. De Servi, and G. Ricevuti Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease Circulation 88 1993 358 363
209. L.M. Biasucci, G. D'Onofrio, and G. Liuzzo Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia J Am Coll Cardiol 27 1996 611 616
210. S. De Servi, A. Mazzone, and G. Ricevuti Clinical and angiographic correlates of leukocyte activation in unstable angina J Am Coll Cardiol 26 1995 1146 1150
211. G. Liuzzo, L.M. Biasucci, and J.R. Gallimore The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina N Engl J Med 331 1994 417 424
212. L.M. Biasucci, A. Vitelli, and G. Liuzzo Elevated levels of interleukin-6 in unstable angina Circulation 94 1996 874 877
213. F. Haverkate, S.G. Thompson, S.D. Pyke, J.R. Gallimore, and M.B. Pepys Production of C-reactive protein and risk of coronary events in stable and unstable angina European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group Lancet 349 1997 462 466
214. W. Koenig, M. Sund, and M. Frohlich C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Circulation 99 1999 237 242
215. M.A. Mendall, P. Patel, L. Ballam, D. Strachan, and T.C. Northfield C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study Br Med J 312 1996 1061 1065
216. S.G. Thompson, J. Kienast, S.D. Pyke, F. Haverkate, and J.C. van de Loo Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group N Engl J Med 332 1995 635 641
217. L.M. Biasucci, G. Liuzzo, and R.L. Grillo Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability Circulation 99 1999 855 860
218. J. Danesh, P. Whincup, and M. Walker Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses Br Med J 321 2000 199 204
219. C.M. Albert, J. Ma, N. Rifai, M.J. Stampfer, and P.M. Ridker Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death Circulation 105 2002 2595 2599
220. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
221. P.M. Ridker, J.E. Buring, J. Shih, M. Matias, and C.H. Hennekens Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women Circulation 98 1998 731 733
222. P.M. Ridker, N. Rifai, M.J. Stampfer, and C.H. Hennekens Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 101 2000 1767 1772
223. P.M. Ridker, N. Rifai, and M. Pfeffer Elevation of tumor necrosis factor-a and increased risk of recurrent coronary events after myocardial infarction Circulation 101 2000 2149 2153
224. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
225. J. Masuda, and R. Ross Atherogenesis during low-level hypercholesterolemia in the non-human primate I. Fatty streak conversion to fibrous plaque Arteriosclerosis 10 1990 178
226. G. Paulsson, X. Zhou, E. Tornquist, and G.K. Hansson Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 20 2000 10 17
227. G.K. Hansson, P. Libby, U. Schonbeck, and Z.Q. Yan Innate and adaptive immunity in the pathogenesis of atherosclerosis Circ Res 91 2002 281 291
228. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
229. A. Tedgui, and Z. Mallat Anti-inflammatory mechanisms in the vascular wall Circ Res 88 2001 877 887
230. C.J. Binder, M.K. Chang, and P.X. Shaw Innate and acquired immunity in atherogenesis Nat Med 8 2002 1218 1226
231. Y.I. Miller, M.K. Chang, C.J. Binder, P.X. Shaw, and J.L. Witztum Oxidized low density lipoprotein and innate immune receptors Curr Opin Lipidol 14 2003 437 445
232. G.K. Hansson Inflammation and immune response in atherosclerosis Curr Atheroscler Rep 1 1999 150 155
233. E. Maggi, G. Finardi, and M. Poli Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk Coron Artery Dis 4 1993 1119 1122
234. E. Maggi, G. Perani, and F. Falaschi Autoantibodies against oxidised low density lipoproteins in patients with coronary disease Presse Med 23 1994 1158 1162
235. C. Monaco, F. Crea, and G. Niccoli Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease: pathophysiological implications Eur Heart J 22 2001 1572 1577
236. F. Crea, C. Monaco, and G.A. Lanza Inflammatory predictors of mortality in the Scandinavian Simvastatin Survival Study Clin Cardiol 25 2002 461 466
237. P. Patel, M.A. Mendall, and D. Carrington Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors Br Med J 311 1995 711 714
238. P. Saikku, K. Laitinen, and M. Leinonen Animal models for Chlamydia pneumoniae infection Atherosclerosis 140 1998 S17 S19
239. P. Saikku, M. Leinonen, and L. Tenkanen Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study Ann Intern Med 116 1992 273 278
240. J.L. Mehta, T.G. Saldeen, and K. Rand Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease J Am Coll Cardiol 31 1998 1217 1225
241. M.A. Mendall, P.M. Goggin, and N. Molineaux Relation of Helicobacter pylori infection and coronary heart disease Br Heart J 71 1994 437 439
242. P.M. Ridker Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? Circulation 97 1998 1671 1674
243. P.M. Ridker, R.B. Kundsin, M.J. Stampfer, S. Poulin, and C.H. Hennekens Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction Circulation 99 1999 1161 1164
244. R. Altman, J. Rouvier, A. Scazziota, R.S. Absi, and C. Gonzalez Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease Clin Cardiol 22 1999 85 90
245. N.J. Wald, M.R. Law, and J.K. Morris Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study Br Med J 321 2000 204 207
246. E. Gurfinkel, G. Bozovich, A. Daroca, E. Beck, and B. Mautner Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study ROXIS Study Group Lancet 350 1997 404 407
247. S. Gupta, E.W. Leatham, and D. Carrington Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction Circulation 96 1997 404 407
248. L.M. Biasucci, G. Liuzzo, and A. Ciervo Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes Circulation 107 2003 3015 3017
249. J. George, Y. Shoenfeld, and A. Afek Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65 Arterioscler Thromb Vasc Biol 19 1999 505 510
250. M. Mayr, S. Kiechl, J. Willeit, G. Wick, and Q. Xu Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and Cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis Circulation 102 2000 833 839
251. G. Wick, M. Knoflach, and Q. Xu Autoimmune and inflammatory mechanisms in atherosclerosis Annu Rev Immunol 22 2004 361 403
252. G. Liuzzo, S.L. Kopecky, and R.L. Frye Perturbation of the T-cell repertoire in patients with unstable angina Circulation 100 1999 2135 2139
253. G. Liuzzo, J.J. Goronzy, and H. Yang Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes Circulation 101 2000 2883 2888
254. B. Kwak, F. Mulhaupt, S. Myit, and F. Mach Statins as a newly recognized type of immunomodulator Nat Med 6 2000 1399 1402
255. C. Monaco, E. Andreakos, and S. Kiriakidis Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis Proc Natl Acad Sci USA 101 2004 5634 5639